Komori
Kaken Pharmaceutical (4521) · PolicyRestated

Policy of treating the stable supply of high-quality pharmaceuticals as a social mission

First written in FY2021-Q1. 6 of 7 entries say "Restated". Latest entry: FY2022.

7entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q1 – FY20222020: 220202021: 320212022: 22022
Same theme, other companies
Stakeholder Contribution through the Continuous Provision of the Best PharmaceuticalsA theme 3 companies write about · 0 as a headwind · 3 as a tailwind

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「We consider the stable supply of high-quality pharmaceuticals to be a social mission. We are also working with our business partners, and stable supply has been maintained. As of the present, there have been no circumstances causing disruptions to the production of our pharmaceuticals or their supply to medical institutions.」

    The company has continued to explain that it treats the stable supply of high-quality pharmaceuticals as a social mission and maintains its supply system through coordination with business partners.
  2. FY2022-Q3RestatedAnnual report

    「We consider the stable supply of high-quality pharmaceuticals to be a social mission. We are also working with our business partners, and stable supply has been maintained」

    The company continues to treat the stable supply of high-quality pharmaceuticals as a social mission and explained that, through coordination with its business partners, there were no disruptions to its production or supply system.
  3. FY2022-Q2RestatedAnnual report

    「We consider the stable supply of high-quality pharmaceuticals to be a social mission. We are also working with our business partners, and stable supply has been maintained」

    The company continues to treat the stable supply of high-quality pharmaceuticals as a social mission and explained that, through coordination with business partners, there were no disruptions to its production or supply system.
  4. FY2021RestatedAnnual report

    「We consider the stable supply of high-quality pharmaceuticals to be a social mission.」

    The company continues to treat the stable supply of high-quality pharmaceuticals as a social mission and explained that, through coordination with business partners, there were no disruptions to its production or supply system for medical institutions.
  5. FY2021-Q3RestatedAnnual report

    「We consider the stable supply of high-quality pharmaceuticals to be a social mission.」

    The policy of treating the stable supply of high-quality pharmaceuticals as a social mission continues to be stated. The company explained that, through coordination with business partners, there were no disruptions to its production or supply system during the current quarter.
  6. FY2021-Q2RestatedAnnual report

    「We consider the stable supply of high-quality pharmaceuticals to be a social mission.」

    The policy of treating the stable supply of high-quality pharmaceuticals as a social mission continues to be stated.
  7. FY2021-Q1First statedAnnual report

    「We consider the stable supply of high-quality pharmaceuticals to be a social mission.」

    In connection with the response to COVID-19, the company has positioned the stable supply of high-quality pharmaceuticals as a social mission.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.